Monoamine oxidase inhibitors (MAOI) are already recognised to prolong and boost the consequences of dimethyltryptamine (copyright) and a single review assumed which the impact on psilocybin would be comparable because it can be a structural analogue of copyright.[145] Even so, only a small part of psilocin appears to get metabolized https://copyright-definition00095.tblogz.com/the-ultimate-guide-to-legal-psychedelics-44562199